inflammation Archives -

KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

https://pharmaphorum.com/partner-content/fishawack-health-welcomes-expert-led-dermatology-initiative-fide-to-its-group/

News/ News/ R&D

Bayer bolsters R&D platform with $2bn Vividion takeover

Phil Taylor Bayer, drug discovery, drug discovery platform, immunology, inflammation, M&A, Oncology, Proteomics, Vividion 0 Comment

Bayer headlined its second-quarter results this morning by unveiling a deal to buy Vividion Therapeutics, saying it will

Bayer bolsters R&D platform with $2bn Vividion takeover

https://pharmaphorum.com/news/bayer-bolsters-rd-platform-with-2bn-vividion-takeover/

Digital/ News/ News

Merck partners neuroloop on bioelectronic device for inflammation

Phil Taylor B Braun, bioelectronics, inflammation, Merck KGaA, neuroloop 0 Comment

Merck KGaA has joined forces with a unit of medtech firm B Braun – neuroloop – on a

Merck partners neuroloop on bioelectronic device for inflammation

https://pharmaphorum.com/news/merck-partners-neuroloop-on-bioelectronic-device-for-inflammation/

News/ News/ R&D

Sanofi begins three-year immunology R&D tie-up with Stanford

Richard Staines immunology, inflammation, R&D, Sanofi, Stanford University 0 Comment

Sanofi has begun a three-year research collaboration with Stanford University School of Medicine, working on better understanding of

Sanofi begins three-year immunology R&D tie-up with Stanford

https://pharmaphorum.com/news/sanofi-begins-three-year-immunology-rd-tie-up-with-stanford-university/

News/ News/ R&D

New CEO Mortazavi takes UK biotech e-therapeutics into gene silencing

Richard Staines Biotech, e-Therapeutics, gene silencing, inflammation, people, R&D 0 Comment

UK biotech e-therapeutics has a new CEO, with executive chairman and former Silence Therapeutics chief Ali Mortazavi chosen

New CEO Mortazavi takes UK biotech e-therapeutics into gene silencing

https://pharmaphorum.com/news/new-ceo-mortazavi-takes-e-therapeutics-into-gene-silencing/

News/ News/ R&D

Roche bulks up in inflammation with €380m Inflazome acquisition

Phil Taylor inflammation, Inflazome, M&A, NLRP3, Roche 0 Comment

Roche has made a second acquisition in the area of NLRP3 inhibitors for inflammatory diseases, buying Irish biotech

Roche bulks up in inflammation with €380m Inflazome acquisition

https://pharmaphorum.com/news/roche-bulks-up-in-inflammation-with-e380m-inflazome-acquisition/

News/ News/ News/ Patients/ R&D

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trial

Phil Taylor coronavirus, immunology, inflammation, Kevzara, Regeneron, Sanofi 0 Comment

Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results

IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trial

https://pharmaphorum.com/news/il-6-hypothesis-looking-shaky-as-kevzara-fails-covid-19-trial/

Market Access/ News/ News/ News/ Patients

FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’

Phil Taylor coronavirus, diagnostic, inflammation, Roche 0 Comment

Roche has been given a green light by the FDA to use one of its diagnostic tests to

FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’

https://pharmaphorum.com/news/fda-clears-emergency-use-of-roche-test-for-covid-19-cytokine-storm/

Digital/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Innovating in inflammation and immunology

George Underwood immunology, inflammation, Pfizer, wearables 0 Comment

For World Inflammatory Bowel Disease day we spoke to Pfizer’s Matt Shaulis, president of international developed markets for

Innovating in inflammation and immunology

https://pharmaphorum.com/r-d/views-analysis-r-d/innovating-in-inflammation-and-immunology/

Trending

inflammation

Login